D-Wave Quantum: $35.5 Million in Bookings, a Class Action and the Revenue Question Today's Q3 Report Must Answer
Published on 11/10/2026 at 13:31 | Editorial boerse-global.de
D-Wave Quantum has spent the past few weeks stacking up product wins, research plaudits and a sector-wide tailwind. Today, before the opening bell, the quantum computing group must show whether any of it converts into revenue.
The company's third-quarter 2026 report lands with a webcast scheduled for 8:00 a.m. ET, where CEO Alan Baratz and acting CFO Greg Golkov are expected to walk investors through the numbers. Analysts are looking for a loss of $0.10 per share and revenue of $4.34 million — a step up from the $3.08 million booked in the second quarter.
Bookings Are Only Half the Story
The headline figure drawing scrutiny is the $35.5 million in customer bookings D-Wave reported for the first half of 2026. That total speaks to genuine economic potential, but only if the agreements behind it turn into shipped systems and recognized revenue on schedule.
That gap between signed contracts and booked sales has become more than an academic question. A securities class action, filed by Rosen Law Firm, alleges that bookings described as record-breaking rested largely on two previously signed contracts, and that system deliveries and associated revenue may have slipped. The claims have not been established in court, and no investor class has yet been certified. Even so, the suit raises the bar for how clearly D-Wave explains where its bookings come from and when they will be delivered.
The cash position gives management room to maneuver while it answers those questions. As of June 30, 2026, D-Wave held $546.2 million in cash and securities. That cushion looks less comfortable against free cash flow of roughly negative $79 million in the first half of 2026 — a burn rate that keeps revenue conversion squarely in the spotlight.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
A Sector Bounce Sets the Stage
The stock climbed 6.6% yesterday, carried higher by strength across quantum computing names. Media reports credited blowout quarterly results and a raised revenue outlook from IonQ for the move. That kind of sector sympathy can lift a share price quickly, but it offers little evidence about a company's own commercial traction — which is why today's filing carries more weight than the prior session's gain.
D-Wave has not been idle on the product front. About a week ago it announced improvements to its hybrid Stride solver; in company-reported benchmarks, the new version reached better solutions in 15 seconds than its predecessor managed in 120. A three-course learning path on applied quantum optimization accompanied the release, aimed at lowering the barrier to using the company's optimization tools.
Roughly two weeks back, D-Wave and LG CNS signed a non-binding memorandum of understanding covering quantum optimization applications and joint marketing in South Korea and international markets. The caveat is built into the structure: an MOU is not a contract, and its value depends entirely on what follows.
Research Wins, With Caveats Attached
Customer projects offer another window into real-world use. Shionogi's quantum computing drug-discovery research took first place in the quality-of-life category of the NEDO Challenge on October 28, with the prize money earmarked for further work.
Clinical research cuts both ways, though. Scientists at Florida Atlantic University, using a D-Wave annealing-based method, reported 94.31% accuracy in simulation and 91.90% on quantum hardware for lung cancer prediction. The announcement itself labeled the findings preliminary and pointed to an expanded dataset — a reminder that promising results still need replication before they carry commercial weight.
What to Watch in the Numbers
For investors, the decisive thread runs from demand through delivery to the income statement. An upside revenue surprise would support the bull case, provided management also lays out a credible path for turning further bookings into recognized sales. If timelines have shifted, the delivery schedule needs to be specific enough for shareholders to judge the financial consequences themselves.
The bull scenario pairs product progress with broader adoption — better tools, trained users and partnerships that mature into concrete applications and commercial relationships. The more demanding scenario arrives if technical advances outpace monetization, forcing the stock to justify its sector-driven optimism with harder operational proof.
D-Wave's opportunity is real, and its balance sheet buys time. The most convincing progress today would be a transparent account of how customer agreements become delivered systems and booked revenue. That, rather than the prior day's rally, is the measure by which the next assessment of the company should be made.
Ad
D-Wave Quantum Stock: New Analysis - 10 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
